The Global Automated External Defibrillator Market size is expected to reach $3.1 billion by 2030, rising at a market growth of 9.6% CAGR during the forecast period. In the year 2022, the market attained a volume of 8,765.9 hundred units, experiencing a growth of 9.0% (2019-2022).
AEDs in the public access segment are often integrated into broader emergency response systems. Consequently, the public access segment captured $248.3 million revenue in the market in 2022. Also, the Germany market consumed 99.8 hundred units by public access in the market in 2022. Public access defibrillation programs aim to deploy AEDs across entire communities. These initiatives increase the density of AEDs in neighbourhoods, enhancing the chances of immediate intervention in the event of sudden cardiac arrest. Some devices have features that automatically notify emergency services when the AED is in use, facilitating a coordinated response.
Telemedicine integration enables healthcare professionals to assess the situation remotely and provide expert consultation on AED usage. AEDs connected to telemedicine services provide immediate access to medical expertise, regardless of the geographical location of the incident. This ensures that individuals in remote or underserved areas can access timely and high-quality medical guidance during critical moments.
Additionally, the senior population is more susceptible to cardiovascular diseases, such as coronary artery disease, heart failure, and arrhythmias. As per the World Health Organization, one in six people will be 60 or older by 2030. The number of people 60 and older in the world will increase from 1 billion in 2020 to 1.4 billion in 2050. By 2050, there will be 2.1 billion people in the world who are 60 or older. It is anticipated that there will be 426 million persons 80 or older by 2050.
However, small businesses with limited budgets can find the costs associated with AED maintenance and training prohibitive. Organizations may depend on external training providers, and the associated costs may vary. Relying on external entities for training can lead to unpredictable expenses, making it challenging for businesses and institutions to budget effectively. Thus, maintenance and training expenses can slow down the growth of the market.
Moreover, the global disruption in manufacturing and supply chains affected the production and distribution of medical devices, including AEDs. Restrictions on movement, lockdowns, and workforce shortages led to delays and disruptions in the supply of AEDs. The pandemic strained healthcare resources, with a significant focus on managing and treating COVID-19 cases. This diversion of resources potentially impacted the attention given to other areas of healthcare, including the promotion and deployment of AEDs.
The market is marked by robust competition among leading players such as Koninklijke Philips N.V., Stryker Corporation, Corpuls, and Nihon Kohden Corporation. This competition is fueled by ongoing technological advancements, a focus on product quality and reliability, expansive distribution networks, adherence to regulatory standards, and strategic pricing tactics. Companies continually strive to differentiate their offerings through innovation while expanding into emerging markets and raising awareness about the critical role of AEDs in public safety, thus intensifying the competitive landscape within the industry.
AEDs in the public access segment are often integrated into broader emergency response systems. Consequently, the public access segment captured $248.3 million revenue in the market in 2022. Also, the Germany market consumed 99.8 hundred units by public access in the market in 2022. Public access defibrillation programs aim to deploy AEDs across entire communities. These initiatives increase the density of AEDs in neighbourhoods, enhancing the chances of immediate intervention in the event of sudden cardiac arrest. Some devices have features that automatically notify emergency services when the AED is in use, facilitating a coordinated response.
Telemedicine integration enables healthcare professionals to assess the situation remotely and provide expert consultation on AED usage. AEDs connected to telemedicine services provide immediate access to medical expertise, regardless of the geographical location of the incident. This ensures that individuals in remote or underserved areas can access timely and high-quality medical guidance during critical moments.
Additionally, the senior population is more susceptible to cardiovascular diseases, such as coronary artery disease, heart failure, and arrhythmias. As per the World Health Organization, one in six people will be 60 or older by 2030. The number of people 60 and older in the world will increase from 1 billion in 2020 to 1.4 billion in 2050. By 2050, there will be 2.1 billion people in the world who are 60 or older. It is anticipated that there will be 426 million persons 80 or older by 2050.
However, small businesses with limited budgets can find the costs associated with AED maintenance and training prohibitive. Organizations may depend on external training providers, and the associated costs may vary. Relying on external entities for training can lead to unpredictable expenses, making it challenging for businesses and institutions to budget effectively. Thus, maintenance and training expenses can slow down the growth of the market.
Moreover, the global disruption in manufacturing and supply chains affected the production and distribution of medical devices, including AEDs. Restrictions on movement, lockdowns, and workforce shortages led to delays and disruptions in the supply of AEDs. The pandemic strained healthcare resources, with a significant focus on managing and treating COVID-19 cases. This diversion of resources potentially impacted the attention given to other areas of healthcare, including the promotion and deployment of AEDs.
By End-use Analysis
Based on end-use, the market is classified into hospital, pre hospital, public access, homecare and others. In 2022, the hospital segment witnessed the 38.14% revenue share in the market. In terms of volume, hospital segment would consume 7,005.3 hundred units by 2030. Hospitals deploy AEDs in critical care units, such as intensive care units (ICUs) and coronary care units (CCUs). These devices respond rapidly to sudden cardiac arrest (SCA) within the hospital setting, complementing the comprehensive care offered to critically ill patients.
By Product Analysis
By product, the market is categorized into fully-automated and semi-automated. The semi-automated segment covered a 29.15% revenue share in the market in 2022. In terms of volume, semi-automated segment would register 5,823.1 hundred units by 2030. Semi-automated AEDs provide a balanced approach by allowing the user to initiate the shock delivery after the device analyzes the heart rhythm. This balance between automated analysis and user-controlled shock delivery enables user involvement while ensuring prompt emergency response.By Regional Analysis
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired a significant revenue share in the market. In terms of volume, Asia Pacific segment consumed 2,384.0 hundred units in 2022. The increasing incidence of cardiovascular diseases in the Asia Pacific region has heightened awareness of the need for effective emergency response measures. Integrating AEDs into emergency medical services (EMS) systems enhances the overall emergency response infrastructure in Asia Pacific.Market Competition and Attributes
The market is marked by robust competition among leading players such as Koninklijke Philips N.V., Stryker Corporation, Corpuls, and Nihon Kohden Corporation. This competition is fueled by ongoing technological advancements, a focus on product quality and reliability, expansive distribution networks, adherence to regulatory standards, and strategic pricing tactics. Companies continually strive to differentiate their offerings through innovation while expanding into emerging markets and raising awareness about the critical role of AEDs in public safety, thus intensifying the competitive landscape within the industry.
Recent Strategies Deployed in the Market
- Oct-2023: Medtronic PLC has received FDA approval for the Aurora EV-ICDTM MRI SureScanTM (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV MRI SureScanTM defibrillation leads to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest (SCA). This Aurora EV-ICD system is a tremendous step forward in implantable defibrillator technology.
- Apr-2023: Defibtech LLC, a subsidiary of Nihon Kohden Corporation, announced the launch of the ARM XR, the next evolution of their automated CPR device. ARM XR is launched for use by emergency medical professionals to treat patients who are in cardiac arrest.
- Apr-2023: Medtronic PLC launched MRI Care Pathway, a new system that can streamline the process of completing MRI scans for patients with Medtronic MRI-compatible cardiac devices. Through this launch, Medtronic is conducting safe MRI scans for patients, which can ultimately reduce a patient’s time waiting for important imaging data.
- Aug-2022: Medtronic PLC came into partnership with BioIntelliSense, a continuous health monitoring and clinical intelligence company for the exclusive U.S. hospital. Through this partnership, the company will provide connected care from in-hospital to home and expand our reach to help more patients in more places than ever before.
List of Key Companies Profiled
- Nihon Kohden Corporation (Defibtech LLC)
- Koninklijke Philips N.V.
- Bpl Medical Technologies Private Limited
- Corpuls (Nordic Capital)
- Progetti SRL
- Stryker Corporation (HeartSine Technologies, Ltd.)
- CU Medical Systems, Inc.
- Silverline Meditech Pvt. Ltd.
- AMI Italia S.r.l.
- Medtronic PLC
Market Report Segmentation
By Product (Volume, Hundred Units, USD Billion, 2019-2030)- Fully-automated
- Semi-automated
- Hospital
- Pre Hospital
- Public Access
- Homecare
- Others
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. Global Automated External Defibrillator Market by Product
Chapter 6. Global Automated External Defibrillator Market by End-use
Chapter 7. Global Automated External Defibrillator Market by Region
Chapter 8. Company Profiles
Companies Mentioned
- Nihon Kohden Corporation (Defibtech LLC)
- Koninklijke Philips N.V.
- Bpl Medical Technologies Private Limited
- Corpuls (Nordic Capital)
- Progetti SRL
- Stryker Corporation (HeartSine Technologies, Ltd.)
- CU Medical Systems, Inc.
- Silverline Meditech Pvt. Ltd.
- AMI Italia S.r.l.
- Medtronic PLC
Methodology
LOADING...
